Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 196

1.

Klinefelter syndrome and fertility: sperm preservation should not be offered to children with Klinefelter syndrome.

Franik S, Hoeijmakers Y, D'Hauwers K, Braat DD, Nelen WL, Smeets D, Claahsen-van der Grinten HL, Ramos L, Fleischer K.

Hum Reprod. 2016 Jul 13. pii: dew179. [Epub ahead of print] Review.

PMID:
27412247
2.

Prediction model for obtaining spermatozoa with testicular sperm extraction in men with non-obstructive azoospermia.

Cissen M, Meijerink AM, D'Hauwers KW, Meissner A, van der Weide N, Mochtar MH, de Melker AA, Ramos L, Repping S, Braat DD, Fleischer K, van Wely M.

Hum Reprod. 2016 Jul 12. pii: dew147. [Epub ahead of print]

PMID:
27406950
3.

Prediction model for live birth in ICSI using testicular extracted sperm.

Meijerink AM, Cissen M, Mochtar MH, Fleischer K, Thoonen I, de Melker AA, Meissner A, Repping S, Braat DD, van Wely M, Ramos L.

Hum Reprod. 2016 Jul 12. pii: dew146. [Epub ahead of print]

PMID:
27406949
4.

Polarization conversion-based molecular sensing using anisotropic plasmonic metasurfaces.

Verre R, Maccaferri N, Fleischer K, Svedendahl M, Odebo Länk N, Dmitriev A, Vavassori P, Shvets IV, Käll M.

Nanoscale. 2016 May 19;8(20):10576-81. doi: 10.1039/c6nr01336h.

PMID:
27153470
5.

Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial.

Smit JG, Kasius JC, Eijkemans MJ, Koks CA, van Golde R, Nap AW, Scheffer GJ, Manger PA, Hoek A, Schoot BC, van Heusden AM, Kuchenbecker WK, Perquin DA, Fleischer K, Kaaijk EM, Sluijmer A, Friederich J, Dykgraaf RH, van Hooff M, Louwe LA, Kwee J, de Koning CH, Janssen IC, Mol F, Mol BW, Broekmans FJ, Torrance HL.

Lancet. 2016 Jun 25;387(10038):2622-9. doi: 10.1016/S0140-6736(16)00231-2. Epub 2016 Apr 27.

PMID:
27132052
6.

The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.

Reijnders IF, Nelen WL, IntHout J, van Herwaarden AE, Braat DD, Fleischer K.

Eur J Obstet Gynecol Reprod Biol. 2016 May;200:45-50. doi: 10.1016/j.ejogrb.2016.02.007. Epub 2016 Feb 27.

PMID:
26967346
7.

Influence of paternal age on ongoing pregnancy rate at eight weeks' gestation in assisted reproduction.

Meijerink AM, Ramos L, Fleischer K, Veltman JA, Hendriks JC, Braat DD.

Reprod Biomed Online. 2016 Jan;32(1):96-103. doi: 10.1016/j.rbmo.2015.09.017. Epub 2015 Oct 22.

PMID:
26615900
8.

Optical characterisation of plasmonic nanostructures on planar substrates using second-harmonic generation.

Persechini L, Verre R, Smith CM, Fleischer K, Shvets IV, Ranjan M, Facsko S, McGilp JF.

Opt Express. 2015 Oct 5;23(20):26486-98. doi: 10.1364/OE.23.026486.

PMID:
26480162
9.

Effect of maternal and treatment-related factors on the prevalence of birth defects after PESA-ICSI and TESE-ICSI: a retrospective cohort study.

Meijerink AM, Oomen RE, Fleischer K, IntHout J, Woldringh GH, Braat DD.

Acta Obstet Gynecol Scand. 2015 Nov;94(11):1245-53. doi: 10.1111/aogs.12728. Epub 2015 Sep 9.

PMID:
26265143
10.

Cytological evaluation of spermatogenesis: a novel and simple diagnostic method to assess spermatogenesis in non-obstructive azoospermia using testicular sperm extraction specimens.

Hessel M, de Vries M, D'Hauwers KW, Fleischer K, Hulsbergen-van de Kaa CA, Braat DD, Ramos L.

Andrology. 2015 May;3(3):481-90. doi: 10.1111/andr.12023. Epub 2015 Apr 8.

11.

The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial.

Nahuis MJ, Weiss NS, van der Veen F, Mol BW, Hompes PG, Oosterhuis J, Lambalk NB, Smeenk JM, Koks CA, van Golde RJ, Laven JS, Cohlen BJ, Fleischer K, Goverde AJ, Gerards MH, Klijn NF, Nekrui LC, van Rooij IA, Hoozemans DA, van Wely M.

BMC Womens Health. 2013 Oct 25;13:42. doi: 10.1186/1472-6874-13-42.

12.

Manipulating and probing the growth of plasmonic nanoparticle arrays using light.

Ualibek O, Verre R, Bulfin B, Usov V, Fleischer K, McGilp JF, Shvets IV.

Nanoscale. 2013 Jun 7;5(11):4923-30. doi: 10.1039/c3nr00087g. Epub 2013 Apr 26.

PMID:
23624613
13.

The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.

Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA.

Thromb Haemost. 2013 Apr;109(4):606-13. doi: 10.1160/TH12-10-0771. Epub 2013 Feb 14.

PMID:
23407778
14.

Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal.

Raps M, Helmerhorst FM, Fleischer K, van Hylckama Vlieg A, Stegeman BH, Thomassen S, Rosendaal FR, Rosing J, Ballieux BE, Van Vliet HA.

J Thromb Haemost. 2013 Feb;11(2):396-7. doi: 10.1111/jth.12080. No abstract available. Erratum in: J Thromb Haemost. 2013 Apr;11(4):790. Van Hylckama, V A [corrected to van Hylckama Vlieg, A].

15.

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.

van Tilborg TC, Eijkemans MJ, Laven JS, Koks CA, de Bruin JP, Scheffer GJ, van Golde RJ, Fleischer K, Hoek A, Nap AW, Kuchenbecker WK, Manger PA, Brinkhuis EA, van Heusden AM, Sluijmer AV, Verhoeff A, van Hooff MH, Friederich J, Smeenk JM, Kwee J, Verhoeve HR, Lambalk CB, Helmerhorst FM, van der Veen F, Mol BW, Torrance HL, Broekmans FJ.

BMC Womens Health. 2012 Sep 18;12:29.

16.

The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial.

Smit JG, Kasius JC, Eijkemans MJ, Koks CA, Van Golde R, Oosterhuis JG, Nap AW, Scheffer GJ, Manger PA, Hoek A, Kaplan M, Schoot DB, van Heusden AM, Kuchenbecker WK, Perquin DA, Fleischer K, Kaaijk EM, Sluijmer A, Friederich J, Laven JS, van Hooff M, Louwe LA, Kwee J, Boomgaard JJ, de Koning CH, Janssen IC, Mol F, Mol BW, Torrance HL, Broekmans FJ.

BMC Womens Health. 2012 Aug 8;12:22. doi: 10.1186/1472-6874-12-22.

17.

Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives.

Raps M, Helmerhorst F, Fleischer K, Thomassen S, Rosendaal F, Rosing J, Ballieux B, VAN Vliet H.

J Thromb Haemost. 2012 Jun;10(6):992-7. doi: 10.1111/j.1538-7836.2012.04720.x.

18.

Controlled in situ growth of tunable plasmonic self-assembled nanoparticle arrays.

Verre R, Fleischer K, McGilp JF, Fox D, Behan G, Zhang H, Shvets IV.

Nanotechnology. 2012 Jan 27;23(3):035606. doi: 10.1088/0957-4484/23/3/035606. Epub 2011 Dec 16.

PMID:
22172777
19.

Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis.

van Vliet HA, Rosendaal FR, Fleischer K, Rosing J, Helmerhorst FM.

Contraception. 2010 Jan;81(1):88-9; author reply 89-90. doi: 10.1016/j.contraception.2009.05.131. Epub . No abstract available.

PMID:
20004280
20.

Spectroscopic ellipsometry and polarimetry for materials and systems analysis at the nanometer scale: state-of-the-art, potential, and perspectives.

Losurdo M, Bergmair M, Bruno G, Cattelan D, Cobet C, de Martino A, Fleischer K, Dohcevic-Mitrovic Z, Esser N, Galliet M, Gajic R, Hemzal D, Hingerl K, Humlicek J, Ossikovski R, Popovic ZV, Saxl O.

J Nanopart Res. 2009 Oct;11(7):1521-1554. Epub 2009 Jun 12.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk